Quarterly report pursuant to Section 13 or 15(d)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Jun. 30, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On June 14, 2024, Yong Ben M.D., a member of the board of directors, adopted a Rule 10b5-1 plan providing for the sale of up to 10,607 shares of the Company’s common stock. Pursuant to this plan, Dr. Ben may sell shares of common stock beginning on September 12, 2024, subject to the terms of the agreement, and the plan terminates on September 11, 2025. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c). No other directors or officers adopted, modified or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the second quarter of 2024.
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Modified	false
Non Rule 10b5-1 Arrangement Modified	false
YongBen [Member]
Trading Arrangements, by Individual
Name	Yong Ben
Title	board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 14, 2024
Rule 10b5-1 Arrangement Terminated	true
Termination Date	September 11, 2025
Arrangement Duration	365 days
Aggregate Available	10,607